Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.News, Bitcoin TreasuryRead More

You might also be interested in reading Money Reimagined: Bitcoin vs. Gold Is a Battle of Narratives.